Motac Neuroscience is a provider of world-class science and innovative technologies to develop new treatments for disorders of the central nervous system


Photo of Washington DC skyline featuring the Washington Monument

Motac will be attending the Neuroscience 2017 Conference in Washington, DC »


Motac provides highly-specialised preclinical services for the pharmaceutical and biotechnology industries to support the discovery and development of therapeutics for neurological and psychiatric disorders. Motac has extensive expertise and world-class research capabilities in neurodegenerative conditions, particularly Parkinson’s disease, other movement disorders and cognitive disorders. We specialise in preclinical proof-of-concept and efficacy studies. Find out more about our company »